Photonics-based Manufacturing Pilot Lines of Paris at COMPAMED 2020 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Photonics-based Manufacturing Pilot Lines

17, rue Hamelin, 75016 Paris

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.


Elena Beletkaia

Project Leader

Francesca Moglia

Project Leader

Ana Gonzalez

Project Leader

David McGovern

Business Development - MedPhab

Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Visit us

17 Nov 2020


10:40 - 12:40

EPIC Online TechWatch on Laser and Photonics Applications at COMPAMED HIGH-TECH FORUM by IVAM

Session: Laser and Photonics Applications
Moderator: Francesca Moglia, Project Leader, EPIC – European Photonics Industry Consortium

  • 10:40 – 11:00 MedPhab – Europe’s First Photonics Pilot Line for Medical Applications –  Ralph Liedert, VTT (MEDPHAB) – Technical Research Center of Finland, Oulu, FN
  • 11:00 – 11:20 Medical photonic technologies to embrace a better life – Prof. Dr. Fokko Pieter Wieringa, imec – Interuniversity Microelectronics Centre, Eindhoven, NL
  • 11:20 – 11:40 Making the Invisible Visible: An New Real-time Imaging Method Beyond the Diffraction Limit for the Life Sciences – Dr. Dominic Zerulla, PEARlabs, Dublin, IE
  • 11:40 – 12:00 Non-invasive glucose monitoring for diabetics based on IR quantum cascade lasers and photothermal detection – Prof. Dr. Werner Mäntele, DiaMonTech, Berlin, DE
  • 12:00 – 12:20 4D OCT for surgical guidance and diagnosis – Dr. Thomas Klein, Optores, Munich, DE
  • 12:20 – 12:40 Using of photoacoustic imaging solutions in early-stage breast cancer detection – Aldas Juronis, EKSPLA, Vilnius, LT

More Less

19 Nov 2020


13:20 - 13:40

Presentation: High-Throughput Roll-to-Roll Manufacturing of Microfluidic Devices

13:20 Presentation by MedPhab partner JOANNEUM RESEARCH Forschungsgesellschaft mbH, join the LIVE stream at

Microfluidics Session: Miniaturization in the Life Sciences – From Hype to Reality
Session Chair: Claudia Gärtner, microfluidic ChipShop GmbH, Jena, DE

  • 11:00 The Promises of Microfluidics-Enabled Point-of-Care Tests: Fast, Cheap and Easy?Holger Becker microfluidic ChipShop GmbH, Jena, DE
  • 11:20 Surface Functionalization in Microfluidics, Alexios Paul Tzannis, IMT Masken und Teilungen AG, Greifensee, CH
  • 11:40 Bioassay Transfer to Microfluidic Scale – Opportunities and Challenges, Luis Fernández microLIQUID S.L., Mondragón, ES
  • 12:00 Piezo Components for Automated Liquid Handling, Annemarie Oesterle, PI Ceramic GmbH, Lederhose, DE
  • 12:20 Disc Pump – the Next Evolutionary Step in Compact, Pulsation Free Microfluidic Control, John Watson, TTP Ventus, Melbourn, GB
  • 12:40 Actively Driven Microfluidic ChipFlorian Siemenroth, Bartels Mikrotechnik GmbH, Dortmund, DE
  • 13:00 Immunophenotyping: Development of a Microfluidic Chip Based on TACS Technology®, Wilhelm Gerdes, Cell.Copedia GmbH, Leipzig, DE
  • 13:20 High-Throughput Roll-to-Roll Manufacturing of Microfluidic Devices, Anja Haase, JOANNEUM RESEARCH Forschungsgesellschaft mbH, Graz, AT
  • 13:40 Towards Highly Sensitive Point-of-Care Testing Using Linear Cryogel ArraysThomas Brandstetter, IMTEK, Freiburg, DE

More Less

Our range of products

Product categories

  • 03  Services
  • 03.02  Consulting (services)
  • 03.02.01  Market access, internationalization

Market access, internationalization

  • 03  Services
  • 03.02  Consulting (services)
  • 03.02.03  Education, training

Education, training

Company news



01 Oct 2020

PIXAPP launches new prototype packaging platforms for early-stage photonic device test and evaluation

PIXAPP, the world’s first open-access Photonic Integrated Circuit (PIC) Assembly and Packaging Pilot line, today announced the introduction of two new prototype packaging platforms to enable the early-stage testing and evaluation of integrated photonic devices.

The PIXAPP Grating Coupler Based Generic Packages (PIXAPP-GCP-10 and PIXAPP-GCP-100) are now available to users that need fast and cost-effective PIC packages with 10s to 100s of electrical connections. “Off-the-shelf” designs are available in volumes from 5 to 1000 units for rapid prototyping using the PIXAPP-GCP-10 design. For PICs with larger electrical and optical connections, the more flexible PIXAPP-GCP-100 design is available. These prototype packages add to PIXAPP’s established advanced photonic packaging services, helping users speed-up the development of their new photonic-based products. The prototype packages offered are based on PIXAPP’s standardised packaging building blocks, including standardised optical and electrical interconnects, thermal and mechanical components.

Since 2017, PIXAPP has led and coordinated efforts with Europe’s leading photonics research institutes and companies to standardise advanced packaging processes and coordinate the manufacturing supply chain, working with design houses, device foundries, companies providing packaging components and services, and manufacturers of automated packaging equipment.

“We are excited about the launch of these new standard prototype packages that support companies in the early stage of product development and evaluation. We believe these packages will benefit users across many application areas, including optical communications, medical devices and other emerging industrial markets” said Peter O’Brien, director of the PIXAPP Pilot Line.

About us: PIXAPP, the world’s first open-access Photonic Integrated Circuit (PIC) Assembly and Packaging Pilot line, provides companies with standardised packaging solutions for prototyping and pilot-scale production. PIXAPP offers a comprehensive building block menu to its users including optical and electrical packaging, thermal control and a variety of mechanical assemblies. PIXAPP is serving key industries such as medical, sensors, security and optical communications. PIXAPP supports the growing demand for PIC-based products by developing standardised packaging processes and by helping to establish a more integrated manufacturing supply chain. A key focus of PIXAPP is to establish a set of packaging design rules and process design kits, providing users with easy access to well-defined and qualified advanced packaging technologies.

More Less

22 Jun 2020

Medical tools developed quicker thanks to new EU Pilot Line

The COVID-19 pandemic has exposed the need to quickly develop diagnostic equipment in the face of a novel threat. Thanks to a dedicated medical pilot production line that gives easy access to prototyping, new medical tools that use photonics to detect major diseases will be quicker, cheaper and easier to develop.

At present, many infectious diseases like COVID-19 or HIV/AIDS do not have an adequate vaccine so patients rely on early, rapid diagnosis for effective treatment and survival. Photonics – the technology based on light – provides healthcare professionals with advanced, highly targeted, minimally invasive diagnostics that detect body signals, symptoms and diseases early on. Developing medical devices, however, can take many years from concept to clinical trials. While researchers and SMEs throughout the world work tirelessly to develop life-saving surgical tools, therapeutics and diagnostic devices, the work is carried out often in small and medium-sized companies, that often struggle to overcome such long and expensive processes. The team behind the pilot line aims to cut the costs involved in research and development of diagnostic devices.So, to speed up the manufacturing of innovative photonics medical equipment, the European Commission has dedicated €15 million to set up a unique, single-point entry medical ‘pilot production line’ under Horizon 2020, the Framework Programme for Research and Innovation.

Easy Access
Called MedPhab, the initiative is the world’s first open-access medical pilot line that enables researchers, SMEs and businesses to turn their diagnostic and treatment devices that use photonics into industrially-relevant demonstrators. The aim is to create easy access for European SMEs, researchers and businesses to a unified infrastructure dedicated to manufacturing, testing, validation and up-scaling of new photonics technologies that are used for medical diagnostics. MedPhab coordinator Jussi Hiltunen said: “MedPhab is Europe’s first Pilot Line dedicated to manufacturing, testing and up-scaling of new photonics technologies for medical diagnostics enabling accelerated product launch with reduced R&D costs. “We are giving researchers a way to develop research and development to market and to bridge the ‘valley of death’ – the impasse often associated with moving from prototyping to low-volume fabrication - while being cost-effective with faster delivery times. “Our easy infrastructure provides the right experts for our clients to help them overcome integrating miniaturised photonic devices.” “When a project leaves MedPhab, their device will be at TRL 6 to 7, at a stage ready for pre-clinical trials, however, our clients can come to us at many different Technology Readiness Levels,” said Hiltunen.

MedPhab focuses on photonics products to tackle one of the biggest societal challenges, the ‘instant diagnosis of major diseases’. With its ability to reveal constituents and visualize incredibly small details in cells and tissues at a molecular level, photonics – the technology that uses and manipulates light – helps doctors and clinicians to understand diseases with greater specificity and sensitivity without being invasive. Helping its clients to implement cutting-edge photonics technologies into their medical diagnostics products, MedPhab believes it will significantly improve health and patient care: “There are exciting opportunities for research into the next generation of photonics-based medical diagnostic devices and MedPhab partners can help academic research groups by providing test devices that are required in pre-clinical studies,” said Hiltunen. New devices from MedPhab technology will improve health and patient care and also generate revenue, job-growth and training opportunities for Europe. This will contribute to the European photonics sector in which 5,000 technology-intensive companies (many of them SMEs) directly employ over 300,000 people.

Use Case Validation Program
To ensure that the prototypes adhere to the highest medical standards, MedPhab selects companies that are validated with ISO13485 standardised manufacturing. ISO13485 is the standard for a Quality Management System for the design and manufacture of Medical Devices, and MedPhab only selected these certified medical companies as part of our production line. “Their participation ensures the seamless transition from pilot line production to up-scaled production without a need for changing service providers,” said Hiltunen. Use-case companies have been selected for the validation of the pilot line services covering both in-vivo and in-vitro domains.

The devices MedPhab focuses on are within three application areas: hospital use, home care devices and equipment for molecular diagnostics. In the hospital setting, solutions assist doctors by giving them real-time information on how a treatment is progressing without the need to send patient samples to a lab. The equipment for home diagnostics can be used for monitoring a patient’s recovery and for obtaining a broader picture than is currently possible. Molecular diagnostics is about establishing a clinical perspective or diagnosing an infection based on a locally-tested serum, saliva or urine sample. The pilot line also focuses on some specific technologies, including Fibre optics, Microfluidics, Surface functionalisation, Instrumentation, Optoelectronic integration, Custom medical patches, Miniaturisation for micromodules and wearables.

The pilot line is coordinated by Teknologian tutkimuskeskus VTT Oy in Finland and includes seventeen other partners from across Europe, including (Ireland) University College Cork - National University of Ireland, Cork, Stryker European Operations Limited, Radisens Diagnostics Limited; (Austria) Joanneum Research Forschungsgesellschaft Mbh, Jabil Circuit Austria Gmbh, Genspeed Biotech Gmbh, Viennalab Diagnostics Gmbh; (Belgium) Interuniversitair Micro-Electronica Centrum, Antelope Dx; (Finland) Screentec Oy, Polar Electro Oy; (Switzerland) Csem Centre Suisse D’electronique Et De Microtechnique Sa - Recherche Et Developpement; (Netherlands) Philips Electronics Nederland Bv, Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis; (France) III-V LAB, European Photonics Industry Consortium;
(Czechia) Amires Sro.

About Photonics21
Photonics21 is the European Technology Platform (ETP) for photonics, a technology encompassing all of the products and processes around the emission, manipulation and detection of light. Photonics is integral to a wide range of industries that include the medical, healthcare, transport, manufacturing, and telecommunications sectors.
“Photonics21” was set up in December 2005 to bring the community of photonics researchers and industries together. The European Commission defined photonics as one of five European Key Enabling Technologies (KET’s) in September 2009. Shortly after, the European Research & Innovation Program “Horizon 2020” invited Photonics21 to become a “Public-Private Partnership” (PPP). The “Photonics 21 Association”, a legal entity under Belgium law, became the private contract partner in November 2013 in a Public-Pri-vate Partnership (PPP) in conjunction with the EU Commission.

Today Photonics21 represents more than 3000 personal members from across Europe and abroad. Our members are experts in the photonics industry, research organisations and universities who actively engage with us to develop a joint photonics strategy for future research and innovation in Europe. With the global photonics market growing from €350 Billion in 2011 to €447 Billion in 2015, Pho-tonics remains a strong industry. The European photonics industry, estimated to be worth €70 billion, has considerable global leader-ship positions and employs over 300,000 people directly.

More Less

About us

Company portrait

The Photonics Based Manufacturing Pilot Lines exhibiting here at COMPAMED are MedPhab Pilot Line, MIRPHAB Pilot Line, JePPIX  Pilot Line and PIXAPP Pilot Line.

MedPhab accelerates the commercialisation of diagnostic devices and instruments for treatment based on photonics, and reduces the R&D cost. Based on testing the validation of the pilot production line on three application areas: hospital environment, home care devices and equipment for chemical diagnostics. MedPhab offers cooperation of a consortium of excellent research institutes and companies that have experience in ISO 13485 standardized manufacturing and/or strong expertise in photonics.

MIRPHAB is an all-service integrated Pilot Line for the development of MID-IR photonics sensors in Europe, a single-access point to the best technology provided by a consortium of leading companies in the field of photonics. MIRPHAB offers services from market analysis, design and fabrication to the final packaging of prototypes. MIRPHAB’s main objective is to transform your ideas into products and to quickly introduce them to the

JePPIX Pilot Line democratizes access to industrial prototyping and pre-production of high-performance InP photonic integrated circuits (PIC). JePPIX Pilot Line has the ambition to transform business practices from vertical integration – where design, fabrication and product development are all in-house and inaccessible to new entrants, to horizontal where fabless and lab less businesses share the same manufacturing infrastructure. JePPIX Pilot Line provides a low entry barrier access to low and medium production volumes of InP PICs.

PIXAPP provides companies with standardized packaging solutions for prototyping and pilot-scale production. PIXAPP offers a comprehensive building block menu to its customers including optical coupling, thermal and mechanical stabilization, serving key industries such as medical, industrial, security and optical communications. PIXAPP aims to drive the future demand for PIC-based products by engaging and standardizing processes along the complete PIC manufacturing supply chain, providing users with easy access to well-defined and qualified packaging technologies.